Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
276
-
Total 13F shares, excl. options
-
76.9M
-
Shares change
-
+4.08M
-
Total reported value, excl. options
-
$5.35B
-
Value change
-
+$251M
-
Put/Call ratio
-
1.02
-
Number of buys
-
167
-
Number of sells
-
-107
-
Price
-
$69.60
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2020
348 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q1 2020.
Guardant Health, Inc. - Common Stock (GH) has 276 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76.9M shares
of 124M outstanding shares and own 62.09% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (23M shares), MORGAN STANLEY (5.01M shares), VANGUARD GROUP INC (4.17M shares), VIKING GLOBAL INVESTORS LP (3.8M shares), Clearbridge Investments, LLC (3.21M shares), BlackRock Inc. (3.02M shares), JENNISON ASSOCIATES LLC (2.6M shares), COATUE MANAGEMENT LLC (2.29M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.84M shares), and ALLIANCEBERNSTEIN L.P. (1.64M shares).
This table shows the top 276 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.